Информация предназначена только для профессионалов в области здравоохранения.
Вы можете зайти как пользователь социальных сетей
ГБОУ ВПО Первый МГМУ им. И.М.Сеченова Минздрава России. 119991, Россия, Москва, ул. Трубецкая, д. 8, стр. 2
Список исп. литературыСкрыть список 1. Валиев Р.Ш., Филатова М.С. Психосоматические соотношения при саркоидозе. Проблемы туберкулеза. 1999; 4: 10–1. / Valiev R.Sh., Filatova M.S. Psikhosomaticheskie sootnosheniia pri sarkoidoze. Problemy tuberkuleza. 1999; 4: 10–1. [in Russian] 2. Визель А.А. Саркоидоз: от гипотезы к практике. Казань: ФЭН. Академия наук РТ, 2004. / Vizel' A.A. Sarkoidoz: ot gipotezy k praktike. Kazan': FEN. Akademiia nauk RT, 2004. [in Russian] 3. Визель А.А., Гурылева М.Э., Визель Е.А. Проблема лечения саркоидоза: повод для дискуссии и проведения контролируемых исследований. Клин. микробиол. антимикроб. химиотер. 2004; 6 (3): 232–42. / Vizel' A.A., Guryleva M.E., Vizel' E.A. Problema lecheniia sarkoidoza: povod dlia diskussii i provedeniia kontroliruemykh issledovanii. Klin. mikrobiol. antimikrob. khimioter. 2004; 6 (3): 232–42. [in Russian] 4. Гурылева М.Э. Качество жизни, этико-правовые проблемы и пути оптимизации медицинской помощи больным саркоидозом (по материалам Республики Татарстан). Автореф. дис. … канд. мед. наук. Казань, 2005. / Guryleva M.E. Kachestvo zhizni, etiko-pravovye problemy i puti optimizatsii meditsinskoi pomoshchi bol'nym sarkoidozom (po materialam Respubliki Tatarstan). Avtoref. dis. … kand. med. nauk. Kazan', 2005. [in Russian] 5. Корнев Б.М. Саркоидоз как системное заболевание. Автореф. дис. … д-ра мед. наук. М., 1999. / Kornev B.M. Sarkoidoz kak sistemnoe zabolevanie. Avtoref. dis. … d-ra med. nauk. M., 1999. [in Russian] 6. Попова Е.Н., Парфенов В.А. Саркоидоз легких хронического течения с поражением нервной системы и сердца. Неврология, нейропсихиатрия, психосоматика. 2009; 1: 46–50. / Popova E.N., Parfenov V.A. Sarkoidoz legkikh khronicheskogo techeniia s porazheniem nervnoi sistemy i serdtsa. Nevrologiia, neiropsikhiatriia, psikhosomatika. 2009; 1: 46–50. [in Russian] 7. Пушкарев Д.Ф. Расстройства личности и хроническая соматическая патология (на модели ревматоидного артрита и хронической обструктивной болезни легких). Автореф. дис. … канд. мед. наук. М., 2013. / Pushkarev D.F. Rasstroistva lichnosti i khronicheskaia somaticheskaia patologiia (na modeli revmatoidnogo artrita i khronicheskoi obstruktivnoi bolezni legkikh). Avtoref. dis. … kand. med. nauk. M., 2013. [in Russian] 8. Саркоидоз. Клинические рекомендации. Под ред. Н.А.Мухина М.: ИМА-ПРЕСС, 2009; с. 95. / Sarkoidoz. Klinicheskie rekomendatsii. Pod red. N.A.Mukhina M.: IMA-PRESS, 2009; s. 95. [in Russian] 9. Хузиева Л.В. Качество жизни и этико-правовые проблемы медицинской помощи больным саркоидозом (медико-социальное исследование). Автореф. дис. … канд. мед. наук. Казань, 2005. / Khuzieva L.V. Kachestvo zhizni i etiko-pravovye problemy meditsinskoi pomoshchi bol'nym sarkoidozom (mediko-sotsial'noe issledovanie). Avtoref. dis. … kand. med. nauk. Kazan', 2005. [in Russian] 10. American Thoracic Society. Statement on sarcoidosis. Am J Res Crit Care Med 1999; 160: 736–55. 11. Antoniou KM, Tzanakis N, Tzouvelekis A et al. Quality of life in patients with active sarcoidosis in Greece. Eur J Int Med 2006; 17: 421–6. 12. Ayuso-Mateos JL, Vazques-Barquero JL, Dowrick C et al. Depressive disorders in Europe: prevalence figures from the ODIN study. Br J Psychol 2001; 179: 308–16. 13. Baumeister H, Korinthenberg K, Bengel J, Härter M. Bronchial asthma and mental disorders – a systematic review of empirical studies. Psychother Psychosom Med Psychol 2005; 55 (5): 247–55. 14. Borson S, Randall Curtis J. Examining the link between sarcoidosis and depression. Am J Res Crit Care Med 2001; 163 (2): 306–8. 15. Briner VA, Müller A, Gebbers JO. Neurosarcoidosis. Schweiz Med Wochenschr 1998; 128 (21): 799–810 16. Chang B, Steimel J, Moller DR et al. Depression in sarcoidosis. Am J Res Crit Care Med 2001; 163 (2): 329–34. 17. Chappell AG, Cheung WY, Hutchings HA. Sarcoidosis: a long-term follow up study. Sarcoidosis Vasc Diffuse Lung Dis 2000; 17 (2): 167–73. 18. Cox CE, Donohue JF, Brown CD et al. Health-related quality of life of persons with sarcoidosis. Chest 2004; 125: 997–1004. 19. Culver DA. Sarcoidosis. clevelandclinicmeded.com. 2010. 20. De Boer S, Kolbe J, Wilsher ML. The relationships among dyspnoea, health-related quality of life and psychological factors in sarcoidosis. Respirology 2014; 19 (7): 1019–24. 21. De Vries J, Drent M. Relationship between perceived stress and sarcoidosis in a Dutch patient population. Sarcoidosis Vasc Diffuse Lung Dis 2004; 21 (1): 57–63. 22. De Vries J, Drent M. Quality of life and health status in sarcoidosis: a review. Semin Respir Crit Care Med 2007; 28 (1): 121–7. 23. De Vries J, Drent M. Quality of life and health status in sarcoidosis: a review of the literature. Clin Chest Med 2008; 29: 525–32. 24. De Vries J, Lower EE, Drent M. Quality of life in sarcoidosis: assessment and management. Semin Respir Crit Care Med 2010; 31(4):485-93 25. De Vries J, Wirnsberger RM. Fatigue, quality of life, and health status in sarcoidosis. Eur Respir Mon 2005; 10: 92–104. 26. Dennolet J. Personality and Risk of Cancer in. Men with Coronary Heart Disease. Psychol Med 1998; 28 (4): 91–5. 27. Drent M, Wirnsberger RM, Breteler MH et al. Quality of life and depressive symptoms in patients suffering from sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis 1998; 15: 59–66. 28. Drent M. Sarcoidosis: benefits of a multidisciplinary approach. Eur J Int Med 2003; 14: 217–20. 29. Drent M, Verbraecken J, van der Grinten C, Wouters E. Fatigue associated with obstructive sleep apnea in a patient with sarcoidosis. Respiration 2000; 67 (3): 337–40. 30. Drent M, Lower EE, de Vries J. Sarcoidosis-associated fatigue. Eur Respir J 2012; 40: 255–63. 31. Elfferich MD, de Vries J, Drent M. Type D or «distressed» personality in sarcoidosis and idiopathic pulmonary fibrosis. Sarcoidosis Vasc Diffuse Lung Dis 2011; 28: 65–71. 32. Erdal BS, Clymer BD, Yildiz VO et al. Unexpectedly high prevalence of sarcoidosis in a representative U.S. Metropolitan population. Resp Med 2012; 106 (6): 893–9. 33. Escande M, Gardes JP, Gayral LF. Reactions and psychic disorders in Besnier – Boeck Schaumann disease: Clinical and psychological approach; application of ascale of aggressive behavior to the mental profile. Ann Med Psychol (Paris) 1980; 138 (7): 813–28. 34. Fleischer M, Hinz A, Brähler E, Wirtz H, Bosse-Henck A. Factors associated with fatigue in sarcoidosis. Res Care 2014. [Epub ahead of print] 35. Foreman MG, Mannino DM, Kamugisha L, Westney GE. Hospitalization for patients with sarcoidosis: 1979–2000. Sarcoidosis Vasc Diffuse Lung Dis 2006; 23 (2): 124–9. 36. Gerke AK, Yang M, Tang F et al. Increased hospitalizations among sarcoidosis patients from 1998 to 2008: a population-based cohort study. BMC Pulm Med 2012; 12: 19. 37. Gerke A.K. Morbidity and mortality in sarcoidosis. Curr Opin Pulm Med 2014; 20 (5): 472–80. 38. Gideon NM, Mannino DM. Sarcoidosis mortality in the United States 1979–1991: an analysis of multiple-cause mortality data. Am J Med 1996: 100 (4): 423–7. 39. Giineylioglu D, Ozseker F, Baran A et al. Sarcoidosis and depression. Europ Resp J 2002; 20 (38): 435. 40. Goracci A, Fagiolini A, Martinucci M et al. Quality of life, anxiety and depression in Sarcoidosis. Gen Hospital Psychiatry 2008; 30: 441–5. 41. Gvozdenovic B, Vucinic V, Zugic V et al. Impairment of the activities of daily living in patients with sarcoidosis. 9th WASOG meeting and 11th BAL conference. Athens, Greece, 2008. 42. Van Helmondt S. Literature review on depressive symptoms in patients with sarcoidosis. Bachelor thesis Psychology and Health Faculty of Social and Behavioral Sciences. Tilburg University, 2010. 43. Hinz A, Brähler E, Möde R et al. Anxiety and depression in sarcoidosis: the influence of age, gender, affected organs, concomitant diseases and dyspnea. Sarcoidosis Vasc Diffuse Lung Dis 2012; 29 (2): 139–46. 44. Holas P, Krejtz I, Urbankowski T et al. Anxiety, its relation to symptoms severity and anxiety sensitivity in sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis 2013; 30 (4): 282–8. 45. Hosoda Y, Sasagawa S, Yasuda N. Epidemiology of sarcoidosis: New frontiers to explore. Curr Opin Pulm Med 2002; 8: 424–8. 46. Ireland J, Wilsher M. Perceptions and beliefs in sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis 2010; 27 (1): 36–42. 47. Judson MA. The Clinical Features of Sarcoidosis: A Comprehensive Review. Clin Rev Allergy Immunol 2014. [Epub ahead of print] 48. King CS, Kelly W. Treatment of sarcoidosis. Dis Mon 2009; 55: 704–18. 49. De Kleijn WPE, Drent M, Vermunt JK et al. Types of fatigue in sarcoidosis patients. J Psychosom Res 2011; 71: 416–22. 50. De Kleijn WPE, Drent M, de Vries J. Nature of fatigue moderates depressive symptoms and anxiety in sarcoidosis. Br J Health Psychol 2013; 9: 1–14. 51. Klonoff EA, Kleinhenz ME. Psychological factors in sarcoidosis: The relationship between life stress and pulmonary function. Sarcoidosis 1993; 10: 118–24. 52. Korenromp I, Heijen CJ, Vogels O et al. Characterization of chronic fatigue in patients with sarcoidosis in clinical remission. Diffuse Lung Dis 2011; 140 (2): 441–7. 53. Korenromp I, Grutters J, van den Bosch J, Heijnen C. Post-inflammatory fatigue in sarcoidosis: personality profiles, psychological symptoms and stress hormones. J Psychosom Res 2012; 72: 97–102. 54. Ligon CB, Judson MA. Impact of systemic corticosteroids on healthcare utilization in patients with sarcoidosis. Am J Med Sci 2011; 341 (3): 196–201. 55. Liu S, Wu R, Li L et al. The Prevalence of Anxiety and Depression in Chinese Asthma Patients. Plos One 2014; 7. 56. Lu Y, Nyunt MS, Gwee X et al. Life event stress and chronic obstructive pulmonary disease (COPD): associations with mental well-being and quality of life in a population-based study. BMJ Open 2012; 2 (6). 57. Lynch JP 3rd, Sharma OP, Baughman RP. Extrapulmonary sarcoidosis. Semin Respir Infect 1998; 13 (3): 229–54. 58. Marcellis RGJ, Lenssen AF, Drent M, de Vries J. Association between physical functions and quality of life in sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis 2014; 31: 117–28. 59. Michielsen HJ, Drent M, Peros-Golubicic T, De Vries J. Fatigue is associated with quality of life in sarcoidosis patients. Chest 2006; 130 (4): 989–94. 60. Muramatsu Y, Muramatsu K, Mashima I, Gejyo F. Bronchial asthma: psychosomatic aspect. JMAJ 2003; 46 (5): 204–7. 61. Rajesh TV, Krishnakumar P, Mathews L. Temperamental traits and psychological problems of children with bronchial asthma. Indian J Pediatr 2008; 45 (9): 772–4. 62. Scano G, Stendardi L, Gigliotti F, Gagliardi E. Dyspnea and emotional states in health and disease. Res Med 2013; 107 (5): 649–55. 63. Sharma OP. Vitamin D, calcium, and sarcoidosis. Chest 1996; 109 (2): 535–9. 64. Sharma OP. Fatigue and sarcoidosis. Eur Respir J 1999; 13: 713–4. 65. Sharma O.P. Neurosarcoidosis: a personal perspective based on the study of 37 patients. Chest 1997; 112 (1): 220–8. 66. Schneider C, Jick SS, Bothner U, Meier CR. COPD and the risk of depression. Chest 2010; 137 (2): 341–7. 67. Spruit MA, Thomeer MJ, Gosselink R et al. Skeletal muscle weakness in patients with sarcoidosis and its relationship with exercise intolerance and reduced health status. Thorax 2005; 60: 32–8. 68. Swigris JJ, Olson AL, Huie TJ et al. Sarcoidosis-related mortality in the United States from 1988 to 2007. Am J Respir Crit Care Med 2011; 183 (11): 1524–30. 69. Trombini G, Trombini E. Sarcoidosis: Psychotherapy and Long-Term Outcome – A Case Report. Case Reports Med 2012–2012: 1–4. 70. Victorson DE, Cella D, Judson MA. Quality of life evaluation in sarcoidosis: current status and future directions. Curr Opin Pulm Med 2008; 14 (5): 470–7. 71. Vögele C, von Leupoldt A. Mental disorders in chronic obstructive pulmonary disease (COPD). Respir Med 2008; 102 (5):764–73. 72. Vučinić V, Stojković M, Milenković B et al. Fatigue in Sarcoidosis: Detection and Treatment. Srp Arh Celok Lek 2012; 140 (1–2): 104–10. 73. Wilsher ML. Psychological stress in sarcoidosis. Curr Opin Pulm Med 2012; 18 (5): 524–7. 74. Wirnsberger RM, De Vries J, Wouters EF et al. Clinical presentation of sarcoidosis in The Netherlands: an epidemiological study. Neth J Med 1998; 53: 53–60. 75. Wirnsberger RM, De Vries J, Jansen TL et al. Impairment of quality of life: rheumatoid arthritis versus sarcoidosis. Neth J Med 1999; 54: 86–95. 76. Yamada Y, Tatsumi K, Yamaguchi T et al. Influence of stressful life events on the onset of sarcoidosis. Respirology 2003; 8 (2): 186–91. 77. Yeager H, Rossman MD, Baughman RP et al. Pulmonary and psychosocial findings at enrollment in the ACCESS study. Sarcoidosis Vas Diffuse Lung Dis 2005; 22: 147–53.